VEDANTA PARTNERS, LLC - 08 Sep 2022 Form 4 Insider Report for REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH)

Role
10%+ Owner
Signature
/s/ Parag Saxena - for Vedanta Partners, LLC, by Parag Saxena, its CEO
Issuer symbol
RVPH
Transactions as of
08 Sep 2022
Net transactions value
+$3,499,999
Form type
4
Filing time
12 Sep 2022, 16:34:34 UTC
Previous filing
03 Jun 2021
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RVPH Pre-Funded Warrant Purchase $2,199,912 +869,565 $2.53 869,565 08 Sep 2022 Common Stock 869,565 $0.000100 See Footnote F1, F2
transaction RVPH Pre-Funded Warrant Purchase $1,299,949 +513,834 $2.53 513,834 08 Sep 2022 Common Stock 513,834 $0.000100 See Footnote F1, F3
transaction RVPH Common Stock Warrant (right to buy) Purchase $86.96 +869,565 $0.000100* 869,565 08 Sep 2022 Common Stock 869,565 $2.40 See Footnote F2, F4
transaction RVPH Common Stock Warrant (right to buy) Purchase $51.38 +513,834 $0.000100* 513,834 08 Sep 2022 Common Stock 513,834 $2.40 See Footnote F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The pre-funded warrants have no expiration date and are exercisable immediately, to the extent that after giving effect to such exercise the reporting person and its affiliates would beneficially own, for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended, no more than 19.99% of the outstanding shares of Common Stock of the Issuer.
F2 Held directly by Beta Operators Fund, L.P. ("Beta Operators Fund"). Vedanta Associates, L.P. ("Vedanta Associates") is the general partner of Beta Operators Fund. Vedanta Partners, LLC ("Vedanta Partners") is the general partner of Vedanta Associates, and Parag Saxena is the majority member of Vedanta Partners. Each of Vedanta Associates, Vedanta Partners and Mr. Saxena disclaim beneficial ownership of the securities reported on this Form 4, except to the extent of any pecuniary interest therein.
F3 Held directly by Vedanta Associates-R, L.P. ("Vedanta Associates-R"). Vedanta Partners is the general partner of Vedanta Associates-R, and Parag Saxena is the majority member of Vedanta Partners. Each of Vedanta Partners and Mr. Saxena disclaim beneficial ownership of the securities reported on this Form 4, except to the extent of any pecuniary interest therein.
F4 The common stock warrants expire on September 8, 2027 and are exercisable immediately, to the extent that after giving effect to such exercise the reporting person and its affiliates would beneficially own, for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended, no more than 19.99% of the outstanding shares of Common Stock of the Issuer.